PACIB: neuroimaging for early-stage diagnoses
A digital service for the analysis and treatment of neuroimaging from Magnetic Resonance (MR) and Computed Tomography (CT)
The PACIB project proposes a platform for the collection, analysis and classification of neuroimaging coming from Magnetic Resonance and of information obtained from the investigation of morpho-functional techniques (CT and PET), concerning patients suffering from neurodegenerative diseases, studied with new radiopharmaceuticals.
PACIB and the new frontiers of the biomedical analysis
Name of project:
PACIB – acquisition, analysis and classification platform of biomedical images for early-stage analysis of neurodegenerative diseases.
Duration:
26 month
Years:
2018-2020
Target markets:
Health Technology
Funding:
European Commission (EC), Region of Lazio
Call for proposals:
POR FESR LAZIO 2014-2020. Public Notice “Creativity 2020”
Total investment of the project:
€ 218.506,00
Contribution funded:
€ 161,094.12
OUR SOLUTION
The PACIB digital service is based on a hardware/software platform for the analysis of biomedical images, which corrects errors introduced by instruments (particularly the partial volume effect). The technology also learns and identifies classification models of such images for early-stage diagnosis and highlights any morphological changes due to medication.
ADVANTAGES
- BETTER DIAGNOSES: PACIB improves the quality of early-stage analysis in two ways:
a. All instrument errrors are continuously corrected;
b. The analysis and classification models of neuroimages provides data and observation with low margins of error; - A MATTER OF HEALTH: PACIB brings advancement to the sector of health information, focused on supporting decision-making processes concerning the patinet’s diagnosis and therapy.